Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

SLNG March 5, 2026

Stabilis Solutions Q4 2025 Earnings Call - Transition year as $200M data-center win and Galveston FID set 2027 growth

Stabilis closed 2025 with a clear pivot. Fourth quarter revenue and adjusted EBITDA fell after two large, multiyear contracts wound down, but management frames 2026 as a transitional year while it bri...

  • Q4 2025 revenue fell 23% year-over-year, driven by a 22% decline in LNG gallons sold and lower rental and service revenue.
  • Two major contracts concluded during Q4, including a truck-to-ship marine bunkering deal with Carnival and a mobile power contract serving a Louisiana electrical cooperative, reducing Q4 revenue by about 28%.
  • Adjusted EBITDA dropped to $1.5 million in Q4, down from $4.0 million the prior year; margin compression partly reflected contract endings and the absence of prior-year non-recurring SG&A adjustments and asset sale gains.
  • +12 more takeaways
ITRN March 5, 2026

Ituran Location and Services Ltd. Q4 2025 Earnings Call - Record revenue and subscribers, big-data and Credit Carbon launched but commercial upside is multi-year

Ituran closed 2025 with its strongest year yet, reporting record quarterly revenue of $93.5 million and full-year revenue of $359 million, driven by a 2.63 million subscriber base and robust subscript...

  • Q4 2025 revenue was $93.5 million, up 13% year-over-year, a company record for a single quarter.
  • Full-year 2025 revenue hit $359 million, up 7% versus 2024, with subscription revenues driving most of the growth.
  • Subscription revenue in Q4 was $71.1 million, up 15% year-over-year, and subscriptions accounted for roughly 74% to 76% of full-year revenues depending on the metric cited.
  • +12 more takeaways
NNBR March 5, 2026

NN, Inc. Q4 2025 Earnings Call - Transformation Largely Complete, Returning to Sales Growth and Margin Expansion in 2026

NN, Inc. closed 2025 with improved profitability after a heavy restructuring, and management says 2026 is the pivot year back to top line growth. The company finished major plant consolidations and he...

  • Q4 2025 net sales were $104.7 million, full year 2025 net sales were $422.2 million, slightly below management hopes but recovering in Q1 2026 due to customers refilling inventories.
  • Adjusted operating income improved to $3.3 million in Q4 and $14.2 million for the full year, roughly three times prior year operating income on an as reported basis.
  • Adjusted EBITDA was $12.9 million in Q4 and $49.0 million for the full year, with adjusted EBITDA margin improving to 12.3% in Q4 and 11.6% for 2025 pro forma.
  • +15 more takeaways
PKOH March 5, 2026

Park-Ohio Holdings Corp. Fourth Quarter 2025 Earnings Call - Reinvestment and Deleveraging Set Stage for 2026 Growth

Park-Ohio closed 2025 with modest revenue improvement in Q4 while completing a year of heavy reinvestment and balance sheet work designed to drive 2026 momentum. Management refinanced debt, cut long t...

  • Park-Ohio returned to sequential and year over year growth in Q4 2025, with consolidated net sales of $395 million, up 2% year over year.
  • Full year 2025 sales were $1.6 billion, down 4% versus 2024, with weakness concentrated in North American industrial end markets.
  • Management reduced long term debt by $40 million in Q4 2025 and refinanced $350 million of senior notes with new senior secured notes maturing in 2030.
  • +12 more takeaways
VSCO March 5, 2026

Victoria's Secret & Co. Fourth Quarter and Fiscal 2025 Earnings Call - Path to Potential drives reacceleration, tariffs are a near-term headwind

Victoria's Secret & Co. closed fiscal 2025 with clear momentum. Q4 comp sales rose 8%, full-year comps were up 5%, and the back half acceleration translated into higher regular-price selling, expandin...

  • Q4 comp sales grew 8%, full-year comps up 5%, marking the highest fourth quarter revenue since Victoria's Secret became an independent public company.
  • Fiscal 2025 net sales, excluding last year’s gift card breakage benefit, were $6.553 billion, a 6% increase year-over-year.
  • Fiscal 2025 adjusted operating income rose 16% to $403 million, and adjusted EPS increased 22% to $3, despite approximately $85 million of net tariff pressure in the year.
  • +14 more takeaways
VSCO March 5, 2026

Victoria's Secret & Co. Fourth Quarter and Fiscal 2025 Earnings Call - Path to Potential drives bras, PINK and beauty momentum

Victoria's Secret & Co. closed fiscal 2025 with clear momentum. Q4 comps rose 8% and full-year comps were up 5%, beating top- and bottom-line guidance as the management-led Path to Potential plan tran...

  • Q4 comp sales +8%; full-year comps +5%; Q4 net sales $2.27 billion, fiscal 2025 net sales $6.553 billion (ex-gift card breakage adjustment).
  • Fiscal 2025 adjusted operating income $403 million (adjusted EPS $3.00), despite roughly $85 million of net tariff pressure for the year.
  • Management says Path to Potential is gaining traction across four pillars: bra authority, PINK reset, beauty growth, and upgraded brand projection/go-to-market.
  • +16 more takeaways
BURL March 5, 2026

Burlington Stores Fiscal 2025 Q4 Earnings Call - Chose Margin Over Sales Amid Tariffs, Now Bullish on 2026

Burlington leaned into margin preservation in 2025, deliberately dialing down receipt plans in higher-tariff categories to protect profitability. The trade paid off: strong margin expansion and double...

  • Q4 headlines: total sales +11% year-over-year, comparable store sales +4%, two-year comp stack +10% for Q4.
  • Q4 profitability: adjusted EBIT margin expanded 100 basis points year-over-year; adjusted EPS $4.99, up 21% vs prior year.
  • Full-year 2025: total sales +9%, comps +2%, operating margin +80 basis points, adjusted EPS growth +22% year-over-year.
  • +13 more takeaways
AMPX March 5, 2026

Amprius Technologies Fourth Quarter 2025 Earnings Call - NDAA-compliant SiCore cells, $125M 2026 guide and a near-term path to positive EBITDA

Amprius closed 2025 with clear commercial momentum and a policy tailwind. Q4 revenue hit a record $25.2 million, full-year revenue was $73 million, and Q4 gross margin improved to 24% as SiCore adopti...

  • Q4 2025 revenue: $25.2 million, up 18% quarter-over-quarter and 137% year-over-year; FY2025 revenue: $73 million, roughly 3x 2024.
  • Q4 gross margin improved to 24%; full-year gross margin was 11% versus negative 76% in 2024, driven by increased SiCore mix and favorable product mix.
  • Management reports full selection of 11 internal cell components from NDAA-compliant countries, claiming a scorecard of 11 out of 11 for country-of-origin requirements.
  • +16 more takeaways
EVGN March 5, 2026

Evogene Ltd. Q4 2025 Earnings Call - Strategic pivot to ChemPass AI targeting small-molecule drug and ag-chemical discovery

Evogene used the Q4 2025 call to make the pivot plain. The company has refocused on a single computational engine, ChemPass AI, and narrowed its market targets to human health small-molecule drug disc...

  • Company strategic pivot: Evogene has concentrated its R&D and commercial strategy on one computational engine, ChemPass AI, and two markets, human health small-molecule drugs and agricultural chemicals.
  • ChemPass AI scale claim: the foundation model was trained or benchmarked on a 38 billion molecule universe and management reported a 90% design precision on internal benchmarks after the first Google Cloud collaboration.
  • Google Cloud partnerships: first collaboration completed mid-2025, second collaboration started February 2026 to integrate advanced AI agents via Vertex AI and automate scientific workflows toward autonomous discovery.
  • +12 more takeaways
UGP March 5, 2026

Ultrapar Q4 2025 Earnings Call - Record BRL 5.5bn Operating Cash, Leverage Comfortable at 1.7x

Ultrapar closed 2025 with a headline few companies would ignore, BRL 5.5 billion of operating cash generation, a record that kept leverage comfortable at 1.7 times even after an anticipated BRL 1.1 bi...

  • Operating cash generation hit a record BRL 5.5 billion in 2025, the single biggest line in the release and the main driver of financial flexibility.
  • Consolidated adjusted EBITDA for Q4 2025 was BRL 1.6 billion, down 34% year-over-year due to non-recurring effects; recurring EBITDA for Q4 was BRL 1.7 billion, up 36% versus Q4 2024.
  • For the full year 2025, adjusted EBITDA reached BRL 6.8 billion, up 2% year-over-year; recurring EBITDA totaled BRL 6.2 billion, a 15% increase versus 2024.
  • +13 more takeaways